Ignite Creation Date:
2024-05-05 @ 5:36 PM
Last Modification Date:
2024-10-26 @ 9:34 AM
Study NCT ID:
NCT00498368
Status:
COMPLETED
Last Update Posted:
2017-02-01
First Post:
2007-07-09
Brief Title:
Rituximab in Progressive Immunoglobulin A IgA Nephropathy
Sponsor:
Mayo Clinic
Organization:
Mayo Clinic
Organization Data
Organization:
Mayo Clinic
Class:
OTHER
Study ID:
07-001944
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Mayo Clinic
Lead Sponsor Class:
OTHER
Responsible Party:
Fernando Fervenza
Responsible Party Title:
MD PhD
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Mayo Clinic
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Biogen | INDUSTRY |
| Ohio State University | OTHER |
| Stanford University | OTHER |
| University of North Carolina Chapel Hill | OTHER |
| Columbia University | OTHER |
| Genentech Inc | INDUSTRY |